Journal of Neurology

, 258:1865

Elevated serum level of interleukin-32α in the patients with myasthenia gravis

  • Sang-Jun Na
  • Seon-Hwa So
  • Kee Ook Lee
  • Young-Chul Choi
Original Communication

DOI: 10.1007/s00415-011-6036-7

Cite this article as:
Na, SJ., So, SH., Lee, K.O. et al. J Neurol (2011) 258: 1865. doi:10.1007/s00415-011-6036-7

Abstract

A new cytokine, interleukin-32 (IL-32), has been implicated in the pro-inflammatory immune responses in several autoimmune disorders, such as rheumatoid arthritis and inflammatory bowel diseases. Myasthenia gravis (MG) is a well-characterized autoimmune disease directed at the postsynaptic acetylcholine receptor (AChR) or end plate of the neuromuscular junction. IL-32 is a cytokine that induces tumor necrosis factor (TNF)-α, IL-6, IL-1β, and chemokine. IL-6, TNF-α, and IL-2 are related to the pathogenesis and immunoregulation of MG. The gene expression of IL-32 is increased in human natural killer (NK) cells and T lymphocytes when stimulated by IL-2 or mitogen. NK cells influence the development of experimental autoimmune MG (EAMG) and possibly MG. The aim of this study was to examine whether IL-32α levels are increased in patients with MG and to investigate the relationship between IL-32α levels and disease activity in human MG. Serum IL-32α levels were significantly higher in the MG patients (p = 0.03): 460.07 ± 192.30 pg/mL in MG patients and 248.45 ± 188.42 pg/mL in the healthy control group. Although there was no significant statistical difference, serum IL-32α levels of patients with both anti-AChR binding and blocking antibodies trended to be higher than those without either antibodies (521.56 ± 212.92 pg/mL vs. 339.52 ± 182.78 pg/mL, p = 0.16). IL-32α serum levels tended to decrease with clinical improvement in generalized MG. This study suggests the possibility that IL-32 might contribute to MG pathogenesis or immunoregulation.

Keywords

Interleukin-32α (IL-32α) Autoimmune disorder Myasthenia gravis (MG) Natural killer cell (NK) 

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Sang-Jun Na
    • 1
    • 2
  • Seon-Hwa So
    • 1
  • Kee Ook Lee
    • 1
    • 2
  • Young-Chul Choi
    • 1
  1. 1.Department of Neurology, Gangnam Severance Hospital, Brain Korea 21 Project for Medical ScienceYonsei University College of MedicineSeoulRepublic of Korea
  2. 2.Department of NeurologyKonyang University College of MedicineDaejeonRepublic of Korea

Personalised recommendations